Free CME from PeerView


Hematology CME

Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Building a Foundation for Enhanced Outcomes in Pediatric ALL: Guidance on the Asparaginase Component of Modern Therapy
Luke Maese, DO / Rachel Rau, MD
May 11, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
The Bedrock of Personalized NF1 Care: Fundamentals of Managing NF1-Associated PNs and Other Tumors With Innovative Targeted Therapy
Laura Klesse, MD, PhD / Carlos G. Romo, MD
May 10, 2023
Credits: 1.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Betting on BCMA in Multiple Myeloma: Oncology Nurse Principles for Delivering Effective Care With BCMA Antibodies and Cellular Therapy
Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO
April 28, 2023
Credits: 1.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Leading Change, Leading Advances in CLL Care: Guidance on Delivering Modern Targeted and Cellular Therapeutics
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
April 27, 2023
Credits: 1.0 CPE
PVI, PeerView Institute for Medical Education
Coordinating Better Outcomes in Multiple Myeloma: Pharmacist Leadership With Novel Antibodies and CAR-T Therapy
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA / Zahra Mahmoudjafari, PharmD, MBA, BCOP
April 14, 2023
Credits: 1.0 CME / MOC / CPE / IPCE
PVI, PeerView Institute for Medical Education
Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effective Care With Targeted Therapy
Emily K. Dotson, PharmD, BCOP
March 31, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease
Stephanie Lee, MD, MPH
March 22, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
The Time Is Now for Outpatient CAR-T: Essential Infrastructure, Lessons From Transplant, and New Evidence
Olalekan Oluwole, MBBS, MD
March 16, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Shaping Modern Management of Myelofibrosis: Guidance on the Conjunction of Targeted Therapy and AlloHCT
Aaron T. Gerds, MD, MS / John Mascarenhas, MD
March 16, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes
James M. Foran, MD, FRCPC / Jessica K. Altman, MD
March 14, 2023
Credits: 1.0 CME
Medical Learning Institute, Inc.
"House Rules" for Innovative Therapy in Multiple Myeloma: Guidance on Integrating Monoclonal Antibodies and BCMA and Non-BCMA Options Into Patient Care
Robert Z. Orlowski, MD, PhD
March 14, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Finding Treatment Synergy in CLL: Expert Consults on Advances With Targeted and Cellular Therapy
Mazyar Shadman, MD, MPH / Peter A. Riedell, MD
March 13, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
New Rules for VOD/SOS: Modern Risk Assessment, Diagnostic Principles, and Innovative Treatment
Prof. Mohamad Mohty / Christine N. Duncan, MD
March 13, 2023
Credits: 1.5 CME / CC
PVI, PeerView Institute for Medical Education
The Precision Team in AML: Exploring Pathologist-Informed Clinical Decisions in Challenging AML Settings
Naval Daver, MD / Joseph D. Khoury, MD, FCAP
March 13, 2023
Credits: 1.0 CME / MOC / CC
PVI, PeerView Institute for Medical Education
Seizing the Precision Care Moment in MDS: Collaborative Strategies for Accurate Diagnoses and Risk-Adapted Treatment
Rami Komrokji, MD
March 13, 2023
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Real-World Challenges and Solutions with BTKi in CLL: Therapeutic Insights for Community Practice
Jennifer Woyach, MD
March 06, 2023
Credits: 0.25 CME / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Real-World Nursing Solutions for AML Care: Insights on the Effective and Safe Delivery of Innovative Therapeutics
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
February 28, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Hitting the BCMA Target in Multiple Myeloma: Insights on CAR-T Therapy and Innovative Antibody Options
Thomas G. Martin, III, MD / Krina Patel, MD, MSc
February 15, 2023
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Innovation Now for Follicular Lymphoma: New Evidence for Immunotherapy, Targeted, and Chemo-Free Options
Loretta J. Nastoupil, MD
February 02, 2023
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL
John C. Byrd, MD
February 02, 2023
Credits: 1.0 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Building a Safety-Centric Culture in B-Cell Cancers: Interprofessional Insights on Optimizing BTKi Efficacy Through Safety Management
Nicole Lamanna, MD
January 31, 2023
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Changing Times for Hemophilia: Exploring Evidence With Novel and Emerging Nonfactor Therapies
Steven W. Pipe, MD
December 30, 2022
Credits: 1.25 CPE
Purdue University College of Pharmacy
Novel Strategies for Managing Patients With CKD-Associated Anemia: What Do Health-System Pharmacists Need to Know About HIF-PH Inhibitors?
Jay B. Wish, MD
December 21, 2022
Credits: 1.25 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
Alexander (Ander) T. Cohen, MBBS, MSc, MD, FRACP, FESC, FRCP
December 16, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Rising Tide of CAR-T in Lymphoma: Guidance on Leveraging Cellular Therapy to Improve Outcomes Across the Spectrum of Care
Jason Westin, MD, MS, FACP
December 09, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
The Winning Way With BTK Inhibitors in CLL: Evidence-Informed Choices on Treatment Selection, Safety, and Therapeutic Sequencing
John C. Byrd, MD
December 09, 2022
Credits: 2.0 CME / MOC
Medical Learning Institute, Inc.
The Road to Remission in Multiple Myeloma: Expert Guidance on Using BCMA-Targeted Options to Enhance Clinical Outcomes
Nikhil C. Munshi, MD
December 09, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Guillermo Garcia-Manero, MD
December 09, 2022
Credits: 2.0 CME / MOC
PSU, Penn State University
Fine-Tuning the Wave of Innovation in CLL: Personalized Models for Upfront and Sequential Care With Groundbreaking Treatment
Prof. John G. Gribben, MD, DSc
December 09, 2022
Credits: 1.5 CME / MOC
Penn State College of Medicine
Real-World, Real Innovation in DLBCL: Perspectives on Integrating Novel Antibody Platforms Into Patient Care
Grzegorz (Greg) Nowakowski, MD
December 09, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView